Interferon-gamma Involvement in the Neuroinflammation Associated with Parkinson's Disease and L-DOPA-Induced Dyskinesia

Autor(es)

Ferrari, D. P. ; Bortolanza, M. ; Del Bel, E. A.

• Tipo de documento: Artigo Científico
• Fonte: NEUROTOXICITY RESEARCH; v. 39, n. 3, p. 15-pg., 2021-03-09.

Resumo

Interferon-gamma (IFN-gamma) is a proinflammatory cytokine that activates glial cells. IFN-gamma is increased in the plasma and brain of Parkinson's disease patients, suggesting its potential role in the disease. We investigated whether the IFN-gamma deficiency could interfere with nigrostriatal degeneration induced by the neurotoxin 6-hydroxydopamine, L-DOPA-induced dyskinesia, and the neuroinflammatory features as astrogliosis, microgliosis, and induced nitric oxide synthase (iNOS) immunoreactivity induced by L-DOPA treatment. Wild type (WT) and IFN-gamma knockout (IFN-gamma/KO) mice received unilateral striatal microinjections of 6-hydroxydopamine. Animals were sacrificed 1, 3, 7, and 21 days after lesions. Additional group of WT and IFN-gamma/KO parkinsonian mice, after 3 weeks of neurotoxin injection, received L-DOPA (intraperitoneally, for 21 days) resulting in dyskinetic-like behavior. Tyrosine hydroxylase immunostaining indicated the starting of dopaminergic lesion since the first day past toxin administration, progressively increased until the third day when it stabilized. There was no difference in the lesion and L-DOPA-induced dyskinesia intensity between WT and IFN-gamma/KO mice. Remarkably, IFN-gamma/KO mice treated with L-DOPA presented in the lesioned striatum an increase of iNOS and glial fibrilary acid protein (GFAP) density, compared with the WT group. Morphological analysis revealed the rise of astrocytes and microglia reactivity in IFN-gamma/KO mice exibiting dyskinesia. In conclusion, IFN-gamma/KO mice presented an intensification of the inflammatory reaction accompanying L-DOPA treatment and suggest that iNOS and GFAP increase, and the activation of astrocytes and microglia induced afterward L-DOPA treatment was IFN-gamma independent events. Intriguingly, IFN-gamma absence did not affect the degeneration of dopaminergic neurons or LID development. (AU)

• Processo FAPESP: 17/14419-4 - Efeito do interferon-³ sobre o parkinsonismo e no desenvolvimento de discinesia induzida pelo tratamento com L-DOPA
• Beneficiário: Daniele Pereira Ferrari
• Modalidade de apoio: Bolsas no Brasil - Mestrado
• Processo FAPESP: 14/25029-4 - Estudo da contribuição do processo inflamatório na discinesia induzida por L-DOPA na Doença de Parkinson
• Beneficiário: Elaine Aparecida Del Bel Belluz Guimarães
• Modalidade de apoio: Auxílio à Pesquisa - Temático